2007
DOI: 10.1007/s10847-006-9193-z
|View full text |Cite
|
Sign up to set email alerts
|

Nimesulide/cyclodextrin/PEG 6000 ternary complexes: physico-chemical characterization, dissolution studies and bioavailability in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
8
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(10 citation statements)
references
References 4 publications
2
8
0
Order By: Relevance
“…Nimesulide belongs to the class-II biopharmaceutical classification drug with a low solubility and high permeability [17,18]. Nimesulide is a weak inhibitor of prostaglandin synthesis in vitro and it appears to show its effects by a variety of mechanisms like free-radical scavenging, involving in neutrophil myeloperoxidase pathway, phosphodiesterase type IV inhibition, histamine release, tumor necrosis factor-alpha release, cartilage degradation, bradykinin activity, metaloprotease synthesis, platelet aggregation, and synthesis of platelet activity factor [19,20] used the Nimesulide in control drug delivery [21,22]. Nimesulide produces gastric irritation in some cases and shows loss of its inhibitory cyclooxygenase-2 (COX-2) selectivity [23,24].…”
Section: Introductionmentioning
confidence: 99%
“…Nimesulide belongs to the class-II biopharmaceutical classification drug with a low solubility and high permeability [17,18]. Nimesulide is a weak inhibitor of prostaglandin synthesis in vitro and it appears to show its effects by a variety of mechanisms like free-radical scavenging, involving in neutrophil myeloperoxidase pathway, phosphodiesterase type IV inhibition, histamine release, tumor necrosis factor-alpha release, cartilage degradation, bradykinin activity, metaloprotease synthesis, platelet aggregation, and synthesis of platelet activity factor [19,20] used the Nimesulide in control drug delivery [21,22]. Nimesulide produces gastric irritation in some cases and shows loss of its inhibitory cyclooxygenase-2 (COX-2) selectivity [23,24].…”
Section: Introductionmentioning
confidence: 99%
“…[40][41][42] Dutet et al, and Ravikumar et al, used the nimesulide in control drug delivery. [43,44] Nimesulide produces gastric irritation in some cases and shows loss of its inhibitory cyclooxygenase-2 (COX-2) selectivity. [45,46] Nimesulide is sparingly soluble in water (0.01 mg/mL).…”
Section: Original Articlementioning
confidence: 99%
“…To overcome these disadvantages, increasing the aqueous solubility is an important goal. Different efforts have been made to improve the aqueous solubility of NIM, such as hotropic solubilization [3], use of surfactants [4,5], cosolvents methods [6], ternary solid dispersions [7] or by complexing NIM with cyclodextrins, where these inclusion complexes have been shown to improve the stability, solubility, dissolution rate, and bioavailability of the drug [8][9][10][11].…”
Section: Introductionmentioning
confidence: 99%
“…Cyclodextrins, with hydrophobic inner cavities and hydrophilic outer surfaces, are capable of interacting with a large variety of hydrophobic or hydrophilic guest molecules to form non-covalent inclusion complexes [13]. Natural CDs especially -CD have been widely used in the early stages of pharmaceutical applications because of their availability and their cavity size, suitable for wide range of drugs in the form of binary systems or ternary systems (supported with polymers) [7,14]. However, the low aqueous solubility and nephrotoxicity of -CD limit its use especially in parenteral route of drug delivery.…”
Section: Introductionmentioning
confidence: 99%